Zobrazeno 1 - 10
of 112
pro vyhledávání: '"Y. Atisha-Fregoso"'
Autor:
A. Carballo‐Muñoz, G. Lima, L. Llorente, Y. A. Remolina‐Bonilla, S. Jaime‐Casas, A. Otamendi‐Lopez, R. A. Ortiz‐Guerra, Hugo E. Velazquez, Y. Atisha‐Fregoso, M. T. Bourlon
Publikováno v:
Cancer Medicine, Vol 13, Iss 18, Pp n/a-n/a (2024)
Abstract Purpose Testicular cancer survivors (TCS) exposed to chemotherapy have an increased expression of CDKN2A/p16INK4a and a lymphocyte phenotype associated with immunosenescence. We seek to define whether the immunosenescent phenotype is associa
Externí odkaz:
https://doaj.org/article/3520f30934eb481e885ea7f4d88062c6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Wendy Gao, Margie Byron, Betty Diamond, Diane L. Kamen, Maria Dall'Era, Cynthia Aranow, Anca D. Askanase, Amit Saxena, Susan A. Boackle, Kristin Ryker, Linna Ding, Patti Tosta, Sai Kanaparthi, Kristina M. Harris, Samir V. Parikh, Kyriakos A. Kirou, Maureen McMahon, S. Sam Lim, William F. Pendergraft, David Wofsy, Dawn E. Smilek, W. Winn Chatham, Susan Malkiel, Amber S. Podoll, Bradley Marder, Y Atisha-Fregoso, William T. Barry, David R. Karp
Publikováno v:
Arthritis & Rheumatology (Hoboken, N.j.)
Arthritis Rheumatol
Arthritis Rheumatol
Objective To assess the safety, mechanism of action, and preliminary efficacy of rituximab followed by belimumab in the treatment of refractory lupus nephritis (LN). Methods In a multicenter, randomized, open-label clinical trial, 43 patients with re
Publikováno v:
J Clin Invest
B cells have a prominent role in the pathogenesis of systemic lupus erythematosus (SLE). They are mediators of inflammation through the production of pathogenic antibodies that augment inflammation and cause direct tissue and cell damage. Multiple th
Autor:
María T. Bourlon, Diego F. Hernández-Ramírez, Guadalupe Lima, Luis Orozco, Y Atisha-Fregoso, Luis Llorente, Hugo E Velázquez, Irene Medina-Rangel, Juan Hinojosa, Ricardo Rios-Corzo, Francisco J. Valentin-Cortez
Publikováno v:
BMC Cancer
BMC Cancer, Vol 20, Iss 1, Pp 1-7 (2020)
BMC Cancer, Vol 20, Iss 1, Pp 1-7 (2020)
Background Cytotoxic chemotherapy can cure advanced germ cell tumors. Nevertheless, cancer treatment may induce cellular senescence and accelerate molecular aging. The aging process implies an increase of cells expressing p16INK4a and changes in lymp
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
J. Jakez-Ocampo, M. Rodriguez-Armida, H. Fragoso-Loyo, G. Lima, L. Llorente, Y. Atisha-Fregoso
Publikováno v:
Clinical Rheumatology. 39:3525-3525
Autor:
Y Atisha-Fregoso, Cynthia Aranow, Silvia A. Calderon, Ashley N. Barlev, Betty Diamond, Meggan Mackay, Jolien Suurmond
Publikováno v:
JCI insight. 4(9)
IgG antinuclear antibodies (ANAs) are a dominant feature of several autoimmune diseases. We previously showed that systemic lupus erythematosus (SLE) is characterized by increased ANA(+) IgG plasmablasts/plasma cells (PCs) through aberrant IgG PC dif
Autor:
Y Atisha-Fregoso, Meggan Mackay, Jolien Suurmond, Cynthia Aranow, Ashley N. Barlev, Betty Diamond, Naveed Ahmed, Emiliano Marasco, Mei Yin Wong, Silvia A. Calderon
BACKGROUND: IgG anti-nuclear antibodies (ANA) are a feature of several autoimmune diseases. These antibodies arise through defects in central or peripheral tolerance checkpoints. The specific checkpoints breached in autoimmune disease are not fully u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a82112db3b6ffb0e595c8704fecf2214
https://europepmc.org/articles/PMC6451885/
https://europepmc.org/articles/PMC6451885/
Autor:
R Ríos-Corzo, J. Jakez-Ocampo, J Ávila-Vázquez, M López-López, A L Pulido-Ramírez, A Díaz-Mora, E Carrillo-Maravilla, J Hernández-Flores, G García-Guevara, Hilda Fragoso-Loyo, Luis Llorente, J Sifuentes-Osornio, Y Atisha-Fregoso
Publikováno v:
Lupus. 27(12)
Background and objective Pneumonia remains the main cause of mortality in patients with systemic lupus erythematosus (SLE). The aim of the study was to establish the clinical characteristics, microbiology and risk factors for poor prognosis in patien